← Latest news 
Agilent and Veeda Launch Bengaluru Center of Excellence for GLP 1 Analytics Ready for Inspections
Technology
Published on 13 May 2026
End to end workflows built to be inspection-ready
Agilent Technologies is partnering with Veeda Lifesciences to launch a joint Center of Excellence in Bengaluru focused on regulatory-aligned analytical and bioanalytical workflows. The hub aims to produce consistent, inspection-ready data across early development, clinical and manufacturing stages, with special emphasis on GLP-1 peptides where sensitivity, throughput and data integrity are crucial. The collaboration combines Agilent mass spectrometry with Veeda proteomics and impurity analysis capabilities.
- Agilent and Veeda will create a Bengaluru CoE for regulatory-aligned analytics
- The focus is end to end workflow development and validation for biopharma
- GLP-1 and other complex biologics need inspection-ready, high integrity datasets
- Agilent mass spectrometry will integrate with Veeda proteomics and impurity analysis
Read the full story at IndianWeb2
This summarization was done by Beige for a story published on 
IndianWeb2